,
4 tweets,
1 min read
Read on Twitter
.@POTUS and I will not stop our work until list prices go down. All options are on the table. We will continue with more regulatory and legislative proposals, and we will work with Democrats and Republicans, until we see list prices come down.
Maintaining the status quo, where higher priced drugs are more competitive and patients pay more, is unacceptable. Companies that announced price increases in January admitted they were doing so to funnel payments back to PBMs in order to keep the preferred status of their drugs.
For those listening in the pharmaceutical industry: The list price increases must stop. Prices must start coming down.
And for those who continue to repeat that list prices don’t matter, let’s remember: Anyone who hasn’t spent through their deductible or has coinsurance is paying all or a percentage of the list price of the drugs they need. List prices matter.
